Clinical trial Recruiting at 3 sites Interventional Ages 18 to 85

3D Ultrasound Support for Hemodialysis Cannulation

Official title: Study of 3D Ultrasound for Support of Hemodialysis Cannulation

Run by Sonavex, Inc. · NCT07891741 · Data updated 2026-11-12

This study tests whether the EchoMap device can help safely cannulate an arm fistula during hemodialysis for adults.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment20 (estimated)
SponsorSonavex, Inc.
Industry-sponsored
Locations3 sites (Hartford, Connecticut and 2 other locations)
StatusRecruiting
StartedMay 7, 2026
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedOctober 27, 2026
Trial IDNCT07891741 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 up to 85 with a mature upper-extremity AV fistula cleared for at least one cannulation and either a history of miscannulation or a need for expert cannulation.

Probably not a fit

Patients with non-mature fistulas, fistulas not cleared for cannulation, or without cannulation difficulties may not experience direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-arm feasibility study conducted at multiple centers to see if EchoMap-assisted cannulation is safe and effective when used with standard cannulation methods for patients with autologous upper-extremity AV fistulas. The study uses a two-stage design to evaluate feasibility in real-world dialysis settings. Participants are adults with a mature fistula cleared for at least one cannulation and with a history of miscannulation or a need for an expert cannulator. Interventions include EchoMap-assisted cannulation along with the standard of care, under appropriate monitoring. Result data will inform whether EchoMap merits broader testing in future research.

Why it matters

Potential benefit: If successful, EchoMap-assisted cannulation could reduce cannulation-related complications and improve fistula longevity and dialysis efficiency.

How similar studies have gone: Prior studies with similar ultrasound-guided or adjunctive cannulation approaches have shown feasibility; this study adds a dedicated EchoMap feasibility evaluation in a multi-center setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> 18 years but \< 85 years of age at the time of informed consent
* Subjects who have received an upper extremity autologous arteriovenous fistula, which has been cleared for at least 1-needle cannulation
* Subjects have a fistula with a history of miscannulation or requires an expert cannulator or have a new fistula that has not previously been cannulated
* Subject is able to sign informed consent and able to participate in all testing associated with this clinical investigation

Exclusion Criteria:

* Age \<18 years old
* Subject unable to sign informed consent.
* Subject is breastfeeding, pregnant, or plans to become pregnant
* Prisoner or Subject from vulnerable populations as defined in 45 CFR 46.
* Subjects that do not have a clinically mature upper extremity AV fistula that is cleared for at least 1-needle cannulation
* Subjects that do not have a fistula with a history of miscannulation or requires an expert cannulator or do not have a new fistula that has not previously been cannulated
* Subjects that are cannulated through a buttonhole technique
* Subjects with a history of poor compliance with the dialysis protocol
* Subjects who have suffered an access related injury or underwent access related intervention in the last 2 weeks

Where it's running

  • Hartford Dialysis
    Hartford, Connecticut, United States
    Recruiting
  • Greater Waterbury Dialysis
    Middlebury, Connecticut, United States
    Recruiting
  • CN Clinical Research
    Greenville, South Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.